Brian Miller

Brian Miller

King & Spalding

Contact
View Bio
RSS

Latest Posts › Disclosure Requirements

Share:

FDA Publishes More Than 200 Complete Response Letters (CRLs) With More to Come

On July 10, 2025, the Food and Drug Administration (FDA) announced that it had published more than 200 complete response letters (CRLs), in response to applications submitted to the FDA for approval of drugs or biological...more

7/14/2025  /  Capital Markets , Compliance , Disclosure Requirements , Drug Approvals , Food and Drug Administration (FDA) , Investors , Pharmaceutical Industry , Regulatory Requirements , Securities Litigation , Shareholders
1 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide